Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Zahra Mohammadzadeh
ScientificTracks Abstracts: J Infect Dis Ther
In-vitro studies indicate a strong antibacterial activity of Hypericum perforatum. However, we found no study on this area in
human. In this double-blind, double dummy trial, we aimed to compare the effect of Hypericum perforatum with metronidazole
vaginal gel on treatment and recurrence (primary outcomes) of bacterial vaginosis (BV) and on patient complaints (secondary
outcomes). 162 married women aged 18-49 with BV were randomized into two groups. The intervention group (n=82) got 5
gram of 3% Hypericum perforatum and placebo of metronidazole vaginal gel, and the control group (n=80) got 5 gram of 0.75%
metronidazole and placebo of hypericum perforatum vaginal gel for 5 days. Amsel criteria were used for diagnosis, cure and
recurrence of BV. We used Chi-square, Fisher’s exact, logistic regression for data analysis.At 10-12 days after starting treatment,
cure rate was 82% in the intervention and 85% in control group (risk ratio (RR) 0.9, 95% confidence interval (CI) 0.6 to 1.3).
Among the cured women, recurrence rate was 9% in the intervention and 13% in the control group at the 30-35 day visit (RR
0.8, 95%CI 0.4 to 1.3). There was no significant difference between the groups regarding any patient complaints, except itching
which was less in Hypericum perforatum group (5% vs. 16%, p=0.018 at the first and 13% vs. 43%, p<0.001 at the second followup).
No significant adverse event was reported at any groups. Therefore, Hypericum perforatum could be a good option for
treatment of BV. However, further studies are needed for its public use.
Zahra Mohammadzadeh have completed her MSc course in the field of midwifery (midwifery education) in 2013 from Tabriz International University of Medical
Sciences (Aras) under the supervision of Dr. Sakineh Mohammad-Alizadeh-Charandabi, Associate Professor of reproductive health. She had more than 18 years
working experience as an expert in midwifery in the hospital, clinic & private office. Currently, working as a midwife in the clinic and also as a medical records expert
in the Social Security Organization.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals